Characteristics | Case (n) | Nucleus ERβ2 | Cytoplasmic ERβ2 | Nucleus ERβ5 | Cytoplasmic ERβ5 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean ± SD | p-value | Mean ± SD | p-value | Mean ± SD | p-value | Mean ± SD | p-value | |||||
Stage (FIGO) | ||||||||||||
Early (I-II) | 49 | 5.46 ± 1.50 | 3.90 ± 1.43 | 6.61 ± 1.10 | 1.86 ± 1.67 | |||||||
Late (III-IV) | 37 | 5.65 ± 1.60 | 0.936* | 3.78 ± 1.40 | 0.701* | 7.11 ± 1.22 | 0.030 * | ↑ | 1.46 ± 1.77 | 0.165* | ||
Histological grade | ||||||||||||
Low (1–2) | 56 | 5.49 ± 1.76 | 3.84 ± 1.58 | 6.88 ± 1.06 | 1.70 ± 1.72 | |||||||
High (3) | 33 | 5.64 ± 1.27 | 0.996* | 3.88 ± 1.32 | 0.784* | 6.82 ± 1.29 | 0.751* | 1.67 ± 1.80 | 0.904* | |||
Histology | ||||||||||||
Serous | 35 | 5.80 ± 1.68 | 4.06 ± 1.24 | 6.89 ± 1.37 | 1.40 ± 1.77 | |||||||
Clear Cell | 17 | 5.71 ± 1.26 | 3.00 ± 2.00 | 7.29 ± 1.11 | 1.06 ± 1.44 | |||||||
Mucinous | 9 | 4.63 ± 2.26 | 3.25 ± 1.49 | 6.22 ± 0.67 | 1.78 ± 1.64 | |||||||
Endometrioid | 29 | 5.40 ± 1.35 | 0.608† | 4.27 ± 1.14 | 0.005 † | 6.70 ± 0.92 | 0.079† | 2.33 ± 1.73 | 0.071† | |||
Serous/Clear Cell | 52 | 5.77 ± 1.54 | 3.71 ± 1.59 | 7.02 ± 1.29 | 1.29 ± 1.66 | |||||||
Mucinous/Endometrioid | 38 | 5.24 ± 1.58 | 0.237* | 4.05 ± 1.27 | 0.246* | 6.59 ± 0.88 | 0.039 * | ↓ | 2.21 ± 1.70 | 0.013 * | ↑ | |
Clear Cell | 17 | 5.71 ± 1.26 | 3.00 ± 2.00 | 7.29 ± 1.11 | 1.06 ± 1.44 | |||||||
Non-Clear Cell | 73 | 5.51 ± 1.64 | 0.580* | 4.05 ± 1.25 | 0.001 * | ↑ | 6.73 ± 1.14 | 0.095* | 1.82 ± 1.77 | 0.134* | ||
Chemosensitivitya | ||||||||||||
Sensitive | 63 | 5.56 ± 1.57 | 3.64 ± 1.36 | 6.84 ± 1.13 | 1.67 ± 1.72 | |||||||
Resistant | 13 | 5.92 ± 1.38 | 0.595* | 4.46 ± 1.66 | 0.105* | 6.92 ± 1.12 | 0.387* | 1.69 ± 1.93 | 0.846* |